hill center2016

March 1-2, 2018

(Links will be activated as information is finalized)

Symposium Agenda


Hotel Information


The 2018 Cardiovascular Bioengineering (CVBE) Symposium is scheduled to be held on the campus of The University of Alabama at Birmingham (UAB) on March 1-2, 2018. This will be the 4th Anniversary of the Symposium.  

The uniqueness of the proposed CVBE symposium lies in its combination of top researchers in cardiovascular bioengineering with underrepresented trainees in the field. Trainees are graduate students and post-doctoral fellows in the cardiovascular sciences and biomedical engineering. The symposium will provide a forum for trainees and junior investigators to present their work in the areas of gene editing, induced pluripotent stem cells, and cardiac stem cells in the context of heart failure as well as general topics in cardiovascular bioengineering.

This conference has previously been held separately from (but in conjunction with) the NIH NHLBI progenitor cell translational consortium (NIH PCTC) for the past 3 years1, 2, 3 by UAB. The meeting became an annual public symposium in 2015 and has been recognized as a unique public and recurring scientific symposium of stem cell and cardiovascular bioengineering. The conference in the past two years has added translational topics to the “bread and butter” of this meeting, which is basic stem cell bioengineering, molecular cardiovascular research, and tissue engineering.

The conference has attracted the world's leading scientists in field of cardiac stem cells. 1, 2, 3, 4   The conference topics started with tissue engineering, iPS cells,  cardiac development, and in the past two years has grown to include exosome, microRNAs, mitochondria,  cardiac gene and cardiac cell therapy. The attendance of this conference has climbed and in 2017, we had attendance of nearly 130.

As in years past, the conference will be held in March. The dates for this year are March 1-2, 2018, held at the Hill Student Center on the campus of UAB.

Organizers of this meeting are Drs. Jianyi (Jay) Zhang (UAB), Tim Kamp (UW-Madison), Gangjian Qin (UAB), and Joel Berry (UAB).


  1. Ogle BM, Bursac N, Domian I, Huang NF, Menasche P, Murry CE, Pruitt B, Radisic M, Wu JC, Wu SM, Zhang J, Zimmermann WH and Vunjak-Novakovic G. Distilling complexity to advance cardiac tissue engineering. Sci Transl Med. 2016;8:342ps13.
  2. Zhu W and Zhang J. Meeting Report for the 2017 National Institutes of Health National Heart, Lung, and Blood Institute Progenitor Cell Biology Consortium: Cardiovascular Bioengineering Workshop and Symposium. Circ Res. 2017;120:1709-1712.
  3. Kannappan R and Zhang J. Meeting Report for NIH 2016 Progenitor Cell Biology Consortium Cardiovascular Tissue Engineering 2016. Circ Res. 2016;119:981-983.
  4. Yanamandala M, Zhu W, Garry DJ, Kamp T, Hare JM, Jun HW, Yoon YS, Bursac N, Prabhu S, Dorn G, Kitsis R, Zhang J. Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering. Journal of the American College of Cardiology (JACC). 2017;70(6):766-775.